Ironwood Pharmaceuticals reported $81.89M in Trade Debtors for its fiscal quarter ending in December of 2024.


Trade Debtors Change Date
Acadia Pharmaceuticals USD 119.69M 5.97M Jun/2025
Agios Pharmaceuticals USD 4.99M 1.64M Jun/2025
Almirall EUR 193.8M 20.72M Jun/2025
Alnylam Pharmaceuticals USD 567.11M 149.08M Jun/2025
Amarin USD 106.73M 15.54M Mar/2025
Ardelyx USD 62.55M 4.84M Jun/2025
Astellas Pharma JPY 699.5B 53.29B Jun/2025
AstraZeneca USD 16.24B 1.42B Jun/2025
Charles River Laboratories USD 767.57M 10.94M Jun/2025
Exact Sciences USD 353.34M 73.54M Jun/2025
Halozyme Therapeutics USD 316.34M 11.72M Jun/2025
Incyte USD 842.89M 19.76M Jun/2025
Ironwood Pharmaceuticals USD 81.89M 5.68M Dec/2024
MacroGenics USD 12.53M 8.22M Jun/2025
Moderna USD 457M 151M Jun/2025
Myriad Genetics USD 120.4M 800K Mar/2025
Pacira USD 114.37M 9.62M Jun/2025
PTC Therapeutics USD 196.13M 14.36M Jun/2025
Sarepta Therapeutics USD 609.6M 114.93M Jun/2025
Takeda JPY 679.53B 45.72B Jun/2025
Ultragenyx Pharmaceutical USD 124.46M 25.62M Jun/2025